FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2749649169> ?p ?o ?g. }

• W2749649169 endingPage "448" @default.
• W2749649169 startingPage "441" @default.
• W2749649169 abstract "Fluid retention is a common adverse event in patients who receive endothelin (ET) receptor antagonist therapy, including the highly selective ETA receptor antagonist, atrasentan. We performed longitudinal assessments of thoracic bioimpedance in patients with type 2 diabetes mellitus and nephropathy to determine whether a decrease in bioimpedance accurately reflected fluid retention during treatment with atrasentan. We conducted a randomized, double-blind, placebo-controlled study in 48 patients with type 2 diabetes mellitus and nephropathy who were receiving stable doses of renin angiotensin system inhibitors and diuretics. Patients were randomized 1:1:1 to placebo, atrasentan 0.5 mg, or atrasentan 1.25 mg once daily for 8 weeks. Thoracic bioimpedance, vital signs, clinical exams, and serologies were taken at weeks 1, 2, 4, 6, and 8, with the exception of serum hemoglobin, which was not taken at week 1, and serum brain natriuretic peptide, which was only taken at baseline, week 4, and week 8. Alterations in bioimpedance were more often present in those who received atrasentan than in those who received placebo, though overall differences were not statistically significant. Transient declines in thoracic bioimpedance during the first 2 weeks of atrasentan exposure occurred before or during peak increases in body weight and hemodilution (decreased serum hemoglobin). We conclude that thoracic bioimpedance did not reflect changes in weight gain or edema with atrasentan treatment in this study. However, the sample size was small, and it may be of interest to explore the use of thoracic bioimpedance in a larger population to understand its potential clinical use in monitoring fluid retention in patients with chronic kidney disease who receive ET receptor antagonists." @default.
• W2749649169 created "2017-08-31" @default.
• W2749649169 creator A5000248736 @default.
• W2749649169 creator A5008309890 @default.
• W2749649169 creator A5023556434 @default.
• W2749649169 creator A5027520502 @default.
• W2749649169 creator A5031624913 @default.
• W2749649169 creator A5034584090 @default.
• W2749649169 creator A5038407839 @default.
• W2749649169 creator A5039655833 @default.
• W2749649169 creator A5041006587 @default.
• W2749649169 creator A5045497276 @default.
• W2749649169 creator A5046497650 @default.
• W2749649169 creator A5060560730 @default.
• W2749649169 creator A5072828158 @default.
• W2749649169 creator A5075086560 @default.
• W2749649169 creator A5080026860 @default.
• W2749649169 creator A5081449769 @default.
• W2749649169 creator A5081782853 @default.
• W2749649169 creator A5087076023 @default.
• W2749649169 date "2017-08-22" @default.
• W2749649169 modified "2023-10-16" @default.
• W2749649169 title "Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial" @default.
• W2749649169 cites W176759912 @default.
• W2749649169 cites W1958247899 @default.
• W2749649169 cites W1988945010 @default.
• W2749649169 cites W1997900205 @default.
• W2749649169 cites W2020685578 @default.
• W2749649169 cites W2039042935 @default.
• W2749649169 cites W2047351161 @default.
• W2749649169 cites W2048443661 @default.
• W2749649169 cites W2051069436 @default.
• W2749649169 cites W2096179755 @default.
• W2749649169 cites W2100732774 @default.
• W2749649169 cites W2109712401 @default.
• W2749649169 cites W2110051876 @default.
• W2749649169 cites W2141250641 @default.
• W2749649169 cites W2147542332 @default.
• W2749649169 cites W2152039674 @default.
• W2749649169 cites W2156753852 @default.
• W2749649169 cites W2162291592 @default.
• W2749649169 cites W2336346210 @default.
• W2749649169 cites W2380725409 @default.
• W2749649169 cites W4255466401 @default.
• W2749649169 doi "https://doi.org/10.1007/s40268-017-0201-0" @default.
• W2749649169 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5629141" @default.
• W2749649169 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28831752" @default.
• W2749649169 hasPublicationYear "2017" @default.
• W2749649169 type Work @default.
• W2749649169 sameAs 2749649169 @default.
• W2749649169 citedByCount "6" @default.
• W2749649169 countsByYear W27496491692019 @default.
• W2749649169 countsByYear W27496491692020 @default.
• W2749649169 countsByYear W27496491692021 @default.
• W2749649169 countsByYear W27496491692022 @default.
• W2749649169 crossrefType "journal-article" @default.
• W2749649169 hasAuthorship W2749649169A5000248736 @default.
• W2749649169 hasAuthorship W2749649169A5008309890 @default.
• W2749649169 hasAuthorship W2749649169A5023556434 @default.
• W2749649169 hasAuthorship W2749649169A5027520502 @default.
• W2749649169 hasAuthorship W2749649169A5031624913 @default.
• W2749649169 hasAuthorship W2749649169A5034584090 @default.
• W2749649169 hasAuthorship W2749649169A5038407839 @default.
• W2749649169 hasAuthorship W2749649169A5039655833 @default.
• W2749649169 hasAuthorship W2749649169A5041006587 @default.
• W2749649169 hasAuthorship W2749649169A5045497276 @default.
• W2749649169 hasAuthorship W2749649169A5046497650 @default.
• W2749649169 hasAuthorship W2749649169A5060560730 @default.
• W2749649169 hasAuthorship W2749649169A5072828158 @default.
• W2749649169 hasAuthorship W2749649169A5075086560 @default.
• W2749649169 hasAuthorship W2749649169A5080026860 @default.
• W2749649169 hasAuthorship W2749649169A5081449769 @default.
• W2749649169 hasAuthorship W2749649169A5081782853 @default.
• W2749649169 hasAuthorship W2749649169A5087076023 @default.
• W2749649169 hasBestOaLocation W27496491691 @default.
• W2749649169 hasConcept C126322002 @default.
• W2749649169 hasConcept C126894567 @default.
• W2749649169 hasConcept C134018914 @default.
• W2749649169 hasConcept C142724271 @default.
• W2749649169 hasConcept C197934379 @default.
• W2749649169 hasConcept C204787440 @default.
• W2749649169 hasConcept C27081682 @default.
• W2749649169 hasConcept C2779922275 @default.
• W2749649169 hasConcept C2908647359 @default.
• W2749649169 hasConcept C42219234 @default.
• W2749649169 hasConcept C555293320 @default.
• W2749649169 hasConcept C71924100 @default.
• W2749649169 hasConcept C99454951 @default.
• W2749649169 hasConceptScore W2749649169C126322002 @default.
• W2749649169 hasConceptScore W2749649169C126894567 @default.
• W2749649169 hasConceptScore W2749649169C134018914 @default.
• W2749649169 hasConceptScore W2749649169C142724271 @default.
• W2749649169 hasConceptScore W2749649169C197934379 @default.
• W2749649169 hasConceptScore W2749649169C204787440 @default.
• W2749649169 hasConceptScore W2749649169C27081682 @default.
• W2749649169 hasConceptScore W2749649169C2779922275 @default.
• W2749649169 hasConceptScore W2749649169C2908647359 @default.
• W2749649169 hasConceptScore W2749649169C42219234 @default.

• next